Year |
Citation |
Score |
2015 |
Jedeszko C, Paez-Ribes M, Di Desidero T, Man S, Lee CR, Xu P, Bjarnason GA, Bocci G, Kerbel RS. Postsurgical adjuvant or metastatic renal cell carcinoma therapy models reveal potent antitumor activity of metronomic oral topotecan with pazopanib. Science Translational Medicine. 7: 282ra50. PMID 25855496 DOI: 10.1126/Scitranslmed.3010722 |
0.426 |
|
2014 |
Ebos JM, Mastri M, Lee CR, Tracz A, Hudson JM, Attwood K, Cruz-Munoz WR, Jedeszko C, Burns P, Kerbel RS. Neoadjuvant antiangiogenic therapy reveals contrasts in primary and metastatic tumor efficacy. Embo Molecular Medicine. 6: 1561-76. PMID 25361689 DOI: 10.15252/Emmm.201403989 |
0.343 |
|
2013 |
Di Matteo P, Hackl C, Jedeszko C, Valentinis B, Bordignon C, Traversari C, Kerbel RS, Rizzardi GP. NGR-TNF, a novel vascular-targeting agent, does not induce cytokine recruitment of proangiogenic bone marrow-derived cells. British Journal of Cancer. 109: 360-9. PMID 23828516 DOI: 10.1038/Bjc.2013.347 |
0.311 |
|
2013 |
Caglič D, Repnik U, Jedeszko C, Kosec G, Miniejew C, Kindermann M, Vasiljeva O, Turk V, Wendt KU, Sloane BF, Goldring MB, Turk B. The proinflammatory cytokines interleukin-1α and tumor necrosis factor α promote the expression and secretion of proteolytically active cathepsin S from human chondrocytes. Biological Chemistry. 394: 307-16. PMID 23152404 DOI: 10.1515/Hsz-2012-0283 |
0.563 |
|
2012 |
Matteo PD, Hackl C, Jedeszko C, Porcellini S, Valentinis B, Bordignon C, Traversari C, Kerbel RS, Rizzardi G. Abstract 4381: The novel direct-acting vascular targeting agent NGR-TNF exertsin vivoantitumor activity by inducing endothelial and tumor cell death in the absence of proangiogenic bone-marrow derived cell recruitment Cancer Research. 72: 4381-4381. DOI: 10.1158/1538-7445.Am2012-4381 |
0.44 |
|
2012 |
Ebos JML, Lee CR, Cruz-Munoz W, Jedeszko C, Kerbel RS. Abstract 1375: Contrasting effects of VEGF pathway inhibitors in primary and metastatic disease using perioperative neoadjuvant mouse models Cancer Research. 72: 1375-1375. DOI: 10.1158/1538-7445.Am2012-1375 |
0.397 |
|
2011 |
Matteo PD, Hackl C, Jedeszko C, Valentinis B, Bordignon C, Traversari C, Kerbel RS, Rizzardi G. Abstract 4249: NGR-TNF, a novel direct-acting vascular targeting agent, does not induce “cytokine-rebound” recruitment of pro-angiogenic bone-marrow derived cells Cancer Research. 71: 4249-4249. DOI: 10.1158/1538-7445.Am2011-4249 |
0.416 |
|
2009 |
Jedeszko C, Victor BC, Podgorski I, Sloane BF. Fibroblast hepatocyte growth factor promotes invasion of human mammary ductal carcinoma in situ. Cancer Research. 69: 9148-55. PMID 19920187 DOI: 10.1158/0008-5472.Can-09-1043 |
0.648 |
|
2009 |
Sameni M, Cavallo-Medved D, Dosescu J, Jedeszko C, Moin K, Mullins SR, Olive MB, Rudy D, Sloane BF. Imaging and quantifying the dynamics of tumor-associated proteolysis Clinical and Experimental Metastasis. 26: 299-309. PMID 19082919 DOI: 10.1007/S10585-008-9218-7 |
0.665 |
|
2008 |
Jedeszko C, Sameni M, Olive MB, Moin K, Sloane BF. Visualizing protease activity in living cells: from two dimensions to four dimensions. Current Protocols in Cell Biology / Editorial Board, Juan S. Bonifacino ... [Et Al.]. Unit 4.20. PMID 18551423 DOI: 10.1002/0471143030.Cb0420S39 |
0.62 |
|
2005 |
Blum G, Mullins SR, Keren K, Fonovic M, Jedeszko C, Rice MJ, Sloane BF, Bogyo M. Dynamic imaging of protease activity with fluorescently quenched activity-based probes. Nature Chemical Biology. 1: 203-9. PMID 16408036 DOI: 10.1038/Nchembio728 |
0.645 |
|
2005 |
Thomas T, Jordan K, Simek J, Shao Q, Jedeszko C, Walton P, Laird DW. Mechanisms of Cx43 and Cx26 transport to the plasma membrane and gap junction regeneration. Journal of Cell Science. 118: 4451-62. PMID 16159960 DOI: 10.1242/Jcs.02569 |
0.355 |
|
2005 |
Brocard CB, Boucher KK, Jedeszko C, Kim PK, Walton PA. Requirement for microtubules and dynein motors in the earliest stages of peroxisome biogenesis. Traffic (Copenhagen, Denmark). 6: 386-95. PMID 15813749 DOI: 10.1111/J.1600-0854.2005.00283.X |
0.359 |
|
2005 |
Podgorski I, Linebaugh BE, Sameni M, Jedeszko C, Bhagat S, Cher ML, Sloane BF. Bone microenvironment modulates expression and activity of cathepsin B in prostate cancer. Neoplasia (New York, N.Y.). 7: 207-23. PMID 15799821 DOI: 10.1593/Neo.04349 |
0.557 |
|
2004 |
Jedeszko C, Sloane BF. Cysteine cathepsins in human cancer. Biological Chemistry. 385: 1017-27. PMID 15576321 DOI: 10.1515/Bc.2004.132 |
0.619 |
|
2003 |
Brocard CB, Jedeszko C, Song HC, Terlecky SR, Walton PA. Protein structure and import into the peroxisomal matrix. Traffic (Copenhagen, Denmark). 4: 74-82. PMID 12559034 DOI: 10.1034/J.1600-0854.2003.40203.X |
0.305 |
|
2002 |
Legakis JE, Koepke JI, Jedeszko C, Barlaskar F, Terlecky LJ, Edwards HJ, Walton PA, Terlecky SR. Peroxisome senescence in human fibroblasts. Molecular Biology of the Cell. 13: 4243-55. PMID 12475949 DOI: 10.1091/Mbc.E02-06-0322 |
0.357 |
|
Show low-probability matches. |